Видео с ютуба Multiple Myeloma

Session 3: January 28, 2026 –Heme Malignancies, Multiple Myeloma, DLBCL, AI-Enabled Precision Onc

Myeloma After Relapse: What New Research Means for Patients

Multiple Myeloma Guidelines 2026: ASCO & Ontario Health Update

毎日の健康記録が大切！【多発性骨髄腫体験談】

Belantamab Mafadotin (Blenrep) -An Antibody Drug Conjugate for Myeloma (content-only cut)

J&J’s Breakthrough: Teclistamab + Daratumumab Smashes PFS Records in Multiple Myeloma

⤴️ New treatments for #Myeloma | Dr. Jesús San Miguel

Multiple Myeloma Explained: A Type of Blood Cancer

Multiple Myeloma Series, Episode 2: Online Resources!

CELMoDs in Multiple Myeloma

Why Myeloma Treatments Stop Working, What Remission Really Means & More | Myeloma Questions Answered

Symposium | Future directions with novel and established BCMA-DT in the MM treatment paradigm

ASH 2025 Multiple Myeloma Highlights | Bispecifics, CAR‑T, Gene Therapy & Market Signals

029 Belantamab Returns: A New Combination for First Relapse Myeloma

Bone Health in Multiple Myeloma - Blood Cancers OncInsights 2025-26

Thrombosis Prevention in Multiple Myeloma - Blood Cancers OncInsights 2025-26

Infection Prevention in Multiple Myeloma - Blood Cancers OncInsights 2025-26

The longest reported survival to date in any unselected group of patients with multiple myeloma

Optimal ferritin threshold to diagnose IEC-HS following CAR T-cell therapy in R/R myeloma

How AI Is Shaping the Future of CAR T and Myeloma Care